ALK-Abelló A/S (CPH:ALK.B)
Denmark · Delayed Price · Currency is DKK 204.60
-5.40 (-2.57%)
Mar 19, 2026, 4:59 PM CET
ALK-Abelló Market Cap
ALK-Abelló has a market cap or net worth of 45.33 billion as of March 19, 2026. Its market cap has increased by 33.86% in one year.
Market Cap
45.33B
Enterprise Value
44.51B
Revenue
6.31B
Ranking
n/a
PE Ratio
37.89
Stock Price
204.60
Market Cap Chart
Since December 27, 2005, ALK-Abelló's market cap has increased from 6.91B to 45.33B, an increase of 556.22%. That is a compound annual growth rate of 9.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 46.53B | -7.98% |
| Dec 30, 2025 | 50.56B | 43.68% |
| Dec 30, 2024 | 35.19B | 57.21% |
| Dec 29, 2023 | 22.38B | 5.48% |
| Dec 30, 2022 | 21.22B | -43.63% |
| Dec 30, 2021 | 37.65B | 37.96% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.11T |
| Genmab | 105.16B |
| Coloplast | 102.09B |
| Demant | 39.27B |
| H. Lundbeck | 36.84B |
| Zealand Pharma | 20.00B |
| Ambu A/S | 18.81B |
| GN Store Nord | 15.32B |